Physician

Alex Navarro Benjamin, M.D.

According to 2025 Medicare claims, Alex Benjamin, M.D. (NPI: 1538329792) practices infectious disease in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY PHYSICIAN GROUP (NPI: 1457412504; TIN: 232700908) and primary practice location at 18103-6202. Benjamin is affiliated with the Lehigh Valley Health Network Accountable Care Organization, LLC (ACO ID: A2735), participating under the MSSP model.

Benjamin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 149 traditional Medicare patients, billed 260 HCPCS/CPT codes, and received $19,540 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 240 prescription claims across 65 beneficiaries totaling $276,204 in drug costs, led by Juluca (Dolutegravir/Rilpivirine). Open Payments data shows 2 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $72,887 to $19,540. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $94,790 and ending at $276,204. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	448	1,045	$72,887
2016	435	1,164	$84,927
2017	473	1,209	$87,351
2018	463	1,053	$82,335
2019	378	996	$88,686
2020	275	571	$45,611
2021	205	284	$21,934
2022	205	296	$21,600
2023	159	756	$23,257
2024	149	260	$19,540

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	138	$94,790
2016	58	192	$308,704
2017	62	359	$370,335
2018	83	366	$487,978
2019	76	279	$281,245
2020	41	172	$125,690
2021	19	43	$18,114
2022	16	48	$12,534
2023	38	118	$129,669
2024	65	240	$276,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	31	31	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	27	41	$93
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	19	28	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	13	14	$59
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	60	78	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Juluca	Dolutegravir/Rilpivirine	20	840	$98,958
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	20	600	$82,695
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	479	$285
Atorvastatin Calcium	Atorvastatin Calcium	14	1,260	$208
Azithromycin	Azithromycin	28	452	$169

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$33	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alex Navarro Benjamin, M.D.?

Tedicare shows public-source Medicare data for Alex Navarro Benjamin, M.D. (NPI 1538329792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Navarro Benjamin, M.D. have ACO affiliation data?

Alex Navarro Benjamin, M.D. is shown with ACO affiliation data for Lehigh Valley Health Network Accountable Care Organization, LLC (MSSP, ACO ID A2735).

What billing organization is linked to Alex Navarro Benjamin, M.D.?

Alex Navarro Benjamin, M.D. is linked to LEHIGH VALLEY PHYSICIAN GROUP (billing NPI 1457412504) in the available physician profile data.

Does Alex Navarro Benjamin, M.D. have Open Payments data?

Alex Navarro Benjamin, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.